Stock listing

Camurus Ab

Selected listing: A2ABG7 · LS · EUR · DE

Camurus Ab (Lang & Schwarz: A2ABG7), Health Technology. Latest release Jul 17, 2026: Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review…

A2ABG7:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A2ABG7
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Camurus Ab

Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA

July 17, 2026

Camurus' Interim Report Second Quarter 2026

July 15, 2026

Change in number of shares and votes in Camurus

June 30, 2026

Camurus provides regulatory update on the US NDA for CAM2029 (Oclaiz™) in acromegaly

June 10, 2026

Camurus : AGM Minutes 2026 (agm minutes 2026)

June 1, 2026

All Camurus Ab news →

Events

Replays

Camurus AB (CAMX) Q2 2026 Earnings Call
Wed, Jul 15, 2026 · 08:00 AM ET
Watch
Camurus AB (CAMX) Q1 2026 Earnings Call
Tue, May 12, 2026 · 08:00 AM ET
Watch
Camurus Ab (CAMRF) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 08:00 AM ET
Watch

Research Camurus Ab

Camurus Ab company profile

View the public company page for Camurus Ab on 6ix.

Camurus Ab news

Read company news and market updates connected to Camurus Ab.

Camurus Ab investor events

Find investor webinars, events, and replay context for Camurus Ab.